GlassScriptPhysician profile
Joni Lynn Prentice
NPI 1669813390
$6,573.76
in general payments reported to CMS, 2019-2025
28 companies · $1,234 in 2025
The $1,234 reported for 2025 was more than what 88% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,483 · 2022: $1,520 · 2023: $963 · 2024: $1,373 · 2025: $1,234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,549 · Education: $21.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,549.14 |
| Education | $21.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,706.61 | 2021-2025 | Farxiga, Wainua |
| Boehringer Ingelheim Pharmaceuticals, INC. | $955.00 | 2021-2025 | Jardiance |
| Medtronic, INC. | $927.71 | 2021-2025 | Symplicity G3, Ffrangio, Onyx Frontier |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $517.98 | 2021-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $470.79 | 2021-2024 | Xarelto |
| Abbott Laboratories | $259.65 | 2022-2025 | Mitraclip, Optis, Cardiomems |
| Esperion Therapeutics, INC. | $237.41 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $172.64 | 2022-2025 | Eliquis, Camzyos |
| Amgen INC. | $170.45 | 2022-2024 | Repatha |
| Shockwave Medical, INC | $155.09 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $146.83 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $145.83 | 2023-2025 | |
| Glaxosmithkline, LLC. | $125.00 | 2021 | |
| Silk Road Medical, INC. | $87.55 | 2022 | |
| Chiesi USA, INC. | $79.55 | 2021-2025 | Kengreal |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daxor Corporation | $72.64 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $48.60 | 2023 | Arcalyst |
| Cardiva Medical, INC. | $47.60 | 2023-2024 | Cardiva Vascade Mvp Vvcs 6-12f, Optowire |
| Kestra Medical Technology Services, INC. | $41.59 | 2024-2025 | Assure Wcd |
| Kiniksa Pharmaceuticals International, Plc | $33.89 | 2024 | Arcalyst |
| Boston Scientific Corporation | $30.29 | 2022 | |
| Impulse Dynamics (USA) INC. | $26.09 | 2023 | Optimizer |
| Scpharmaceuticals INC. | $24.05 | 2024 | |
| Procyrion, INC. | $23.15 | 2024 | |
| Hologic Sales and Service, LLC | $21.94 | 2025 | Myosure Tissue Removal Device |
| Ancora Heart, INC. | $17.42 | 2024 | Accucinch |
| Alnylam Pharmaceuticals INC. | $14.60 | 2024 | Amvuttra |
| Merck Sharp & Dohme LLC | $13.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joni Prentice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.